FIELD: medicine.
SUBSTANCE: transdermal composition according to the present invention contains highly concentrated donepezil in a hydrophobic matrix, can continuously release a drug for a long period of time, having long-term adhesion to skin, and exhibits an effective therapeutic effect for a long period of time, having an improved skin penetration rate compared to traditional patches with donepezil.
EFFECT: present invention relates to a transdermal composition for treating dementia containing donepezil as an active ingredient.
14 cl, 19 ex, 4 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TRANSDERMAL DRUG FOR TREATMENT OF DEMENTIA CONTAINING DONEPEZIL | 2018 |
|
RU2775315C2 |
| TRANSDERMALLY ABSORBABLE FORMULATION CONTAINING DONEPEZIL | 2010 |
|
RU2545696C2 |
| PERCUTANEOUS DELIVERY SYSTEM, USING MICROPOROUS MEMBRANE CONTAINING PORES FILLED WITH SOLVENT | 2018 |
|
RU2789194C2 |
| TRANSDERMAL DONEPEZIL DELIVERY SYSTEM | 2017 |
|
RU2779471C2 |
| NEW ADHESIVE PREPARATION | 2007 |
|
RU2445959C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM | 2020 |
|
RU2791107C1 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL INJECTION OF GUANFACINE, CONTAINING SILICONE POLYMER | 2018 |
|
RU2792822C2 |
| COMPOSITION FOR TRANSCUTANEOUS DELIVERY OF MEDICATION | 2008 |
|
RU2449766C2 |
| PERCUTANEOUS DRUG DELIVERY COMPOSITION (VERSIONS), METHOD OF PRODUCTION AND APPLICATION | 2002 |
|
RU2358699C2 |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR TRANSDERMAL ADMINISTRATION OF GUANFACINE CONTAINING AT LEAST ONE EXCIPIENT | 2018 |
|
RU2812734C2 |
